Moneycontrol PRO
Loans
Loans
HomeNewsA velumani

A Velumani

Jump to
  • Thyrocare's Velumani urges recruiters to hire poor and humble employees 'for long term success'

    Thyrocare's Velumani urges recruiters to hire poor and humble employees 'for long term success'

    Drawing from experience, Thyrocare CEO A Velumani suggests hiring humble individuals for business success, a sentiment shared by Zoho's Sridhar Vembu regarding untapped rural talent.

  • Thyrocare founder's advice for professionals is viral amid mass layoffs across sectors: 'Don’t celebrate...'

    Thyrocare founder's advice for professionals is viral amid mass layoffs across sectors: 'Don’t celebrate...'

    'Don’t celebrate too early. Career or business – it’s a marathon race,' A Velumani wrote, drawing attention to the emotional turmoil faced by professionals during mass layoffs. He highlighted how many young graduates celebrate landing jobs with top global brands, only to face unexpected job losses later.

  • Thyrocare founder wants to invest 'minimum Rs 100 crore' in goat farming business

    Thyrocare founder wants to invest 'minimum Rs 100 crore' in goat farming business

    Realising that the idea may take many by surprise, Thyrocare founder Dr Arokiaswamy Velumani revealed that goat farming was his first failure in life and he was only 10.

  • Emotional Dr Velumani says he “moved fast for a change” as he sold Thyrocare to PharmEasy

    Emotional Dr Velumani says he “moved fast for a change” as he sold Thyrocare to PharmEasy

    Dr A Velumani and his family will sell their 66.1 percent stake in Thyrocare to PharmEasy for Rs 4,546 crore. It’s a bumper value-unlocking for the family in the best year possible for the diagnostics business during the pandemic. The need for a change and de-risking are some of the key reasons for the sale, said Dr Velumani.

  • Coronavirus | Thyrocare Technologies launches 'COVID Antibody Tests'

    Coronavirus | Thyrocare Technologies launches 'COVID Antibody Tests'

    The test kits and procedures have been approved by ICMR, and the company has made the test available pan India, Thyrocare said in a statement.

  • V-Guard: Aiming for more than just stability

    V-Guard: Aiming for more than just stability

    The following article is an initiative of Thyrocare & CNBC TV-18 and is intended to create awareness among the users.

  • The Chennai Silks: Spinning a success story

    The Chennai Silks: Spinning a success story

    The following article is an initiative of Thyrocare & CNBC TV-18 and is intended to create awareness among the users.

  • Health for wealth, the TransAsia way!

    Health for wealth, the TransAsia way!

    The following article is an initiative of Thyrocare & CNBC TV-18 and is intended to create awareness among the users.

  • Balaji Wafers: A chip of the new block

    Balaji Wafers: A chip of the new block

    The following article is an initiative of Thyrocare & CNBC TV-18 and is intended to create awareness among the users.

  • Learning lessons from poverty

    Learning lessons from poverty

    The following article is an initiative of Thyrocare & CNBC TV-18 and is intended to create awareness among the users.

  • Luxury of Poverty: Dr Velumani's take on BVG India

    Luxury of Poverty: Dr Velumani's take on BVG India

    Watch accompanying videos wherein A Velumani, Founder of Thyrocare Health Technologies decodes the success story of Hanmant Gaikwad, the man who built BVG India.

  • Luxury of Poverty: Decoding the success mantras of V-Guard

    Luxury of Poverty: Decoding the success mantras of V-Guard

    Luxury of Poverty, presented by Thyrocare and CNBC-TV18, focuses on stories that give you hope and confidence that anyone can make it big in the world of business. Take a look at A Velumani, Founder of Thyrocare Health Technologies decode the success story of V-Guard.

  • The Luxury of Poverty: Know more about Thyrocare's A Velumani

    The Luxury of Poverty: Know more about Thyrocare's A Velumani

    Know more about the Chairman of Thyrocare Technologies, Dr A Velumani in this of episode of - The Luxury of Poverty-Winning against all odds.

  • Aim to sustain 25% topline growth in FY17: Thyrocare

    Aim to sustain 25% topline growth in FY17: Thyrocare

    Thyrocare Technologies is betting big on the radiology vertical which requires huge capex, but is capable of bringing in good business, says Chairman, CEO & MD A Velumani.

  • Thyrocare chief sees a sales growth of 25% in third quarter

    Thyrocare chief sees a sales growth of 25% in third quarter

    Diagnostics company Thyrocare Technologies felt the blow of demonetisation in the month of November but was back on its feet and saw growth at 24 percent in the month under review.

  • Thyrocare hopeful of growing revenues 25% in FY17

    Thyrocare hopeful of growing revenues 25% in FY17

    Thyrocare‘s revenue grew 21.7 percent to Rs 69.36 crore and operating profit margins improved to 39.4 percent in the first quarter of FY17.

  • Targetting 4-fold increase in labs in next year: Thyrocare

    Targetting 4-fold increase in labs in next year: Thyrocare

    With a capex of Rs 75 crore, Thyrocare Technologies‘ CEO A Velumani is confident of increasing its reach with 25 laboratories in the coming year. He expects the company to clock a CAGR of 25-35% in the next few years.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347